INO

INOVIO PHARMACEUTICALS INC

INO·45773H409·US·Common Stock·Healthcare - Biotechnology-13D/G

INO (INOVIO PHARMACEUTICALS INC) is held by 48 institutional investors as of Q1 2026. Largest holders: FMR LLC ($16.3M), Janus Henderson Group Ltd. ($5.8M), VANGUARD CAPITAL MANAGEMENT LLC ($5M). Net institutional sentiment: Mixed.

48
Holders
Avg rating(14 Elite)
$43M
Total Value
50% (56)
Fund Consensus
23 buying - 23 selling
INOSmart Money Verdict
View all
Held by 48 funds
14 elite
Who's Trading
ActivistHIHIGHBRIDGE CAPITAL MANAGEMENT LLC8.2%May 15, 2026
ActivistADAdage Capital Management, L.P.5.8%May 13, 2026
ActivistFMR LLCFMR LLC13.5%May 6, 2026
ActivistAIAlyeska Investment Group, L.P.6.0%Feb 17, 2026
ActivistThe Vanguard GroupThe Vanguard Group5.0%Jan 30, 2026
ActivistJANUS HENDERSON GROUP PLCJANUS HENDERSON GROUP PLC10.0%Dec 8, 2025
ActivistDTDeep Track Capital, LP2.4%Nov 14, 2025
ActivistBlackRock, Inc.BlackRock, Inc.1.5%Jul 17, 2025
ActivistSTStonepine Capital Management, LLC3.8%May 14, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
9.3M(-5.2%)$16.3M0.0%-32.95%
0
Unchanged
3.3M$5.8M0.0%-51.47%
0
New
2.9M$5M0.0%-29.76%
37
Decreased
2.2M(-0.8%)$3.9M0.0%-41.17%
0
Increased
1.4M(+0.5%)$2.5M0.0%-50.38%
26
Decreased
804,958(-68.5%)$1.4M0.0%-51.64%
0
Increased
801,504(+4.2%)$1.4M0.0%-92.62%
27
Increased
662,181(+7.2%)$1.2M0.0%-33.07%
18
Increased
643,777(+16.4%)$1.1M0.0%-56.02%
29
New
392,066$682,1950.0%-29.76%
34
Increased
390,384(+21.0%)$679,2680.0%-44.36%
29
Decreased
298,870(-0.4%)$520,0340.0%-90.30%
0
Increased
296,310(+19.8%)$515,5790.0%-71.72%
20
New
286,352$498,2520.0%-29.76%
33
Increased
249,650(+46.4%)$434,3920.0%-43.34%
33
Increased
212,677(+27.3%)$370,0580.0%-46.89%
29
Decreased
63,864(-39.6%)$111,1250.0%-59.37%
0
Decreased
56,862(-77.3%)$98,9400.0%-37.39%
0
New
50,000$87,0000.0%-29.76%
30
Increased
44,724(+63.9%)$77,8200.0%-32.58%
21

Showing 1-20 of 56

1 / 3

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used